How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,473 results for

Laser Skin Procedure

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Local and systemic effects of low-level light therapy with light-emitting diodes to improve erythema after fractional ablative skin resurfacing: a controlled study. (Abstract)

Local and systemic effects of low-level light therapy with light-emitting diodes to improve erythema after fractional ablative skin resurfacing: a controlled study. Therapy with light-emitting diodes (LED) has been associated with the reduction of erythema and accelerated wound healing. LED phototherapy has been used in various clinical practices including post-laser wound healing enhancement. Fractional laser resurfacing is one of the popular dermatological procedures; however, the duration (...) -treated side compared with the control CO2 only group. 830/590 nm LED-LLLT may provide both local and systemic effects on the degree of post-ablative laser erythema in human skin, however, appropriate protocol settings should be considered to achieve a significant clinical outcome.

2018 Lasers in medical science Controlled trial quality: uncertain

102. To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin

corticosteroids, tacrolimus, retinoids in the last 2 months or other treatments that may affect hair growth Platelet rich plasma (PRP) treatment on scalp during the last 12 months Systemic therapy using retinoids, cyclosporine within the last 3 months Systemic treatment with beta blockers or corticosteroids, scalp procedures e.g. surgery, laser, light, micro-needling within the last 6 months Finasteride (e.g. Propecia®) or Dutasteride intake in the last 12 months, or any systemic hair therapy medication (...) To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. To Investigate Efficacy of FOL

2018 Clinical Trials

103. A Pilot Study on the Use of Platelet Rich Plasma (PRP) for Facial and Hand Skin Rejuvenation

months if able to conceive Patients are able and willing to provide written informed consent after the study is fully explained Exclusion Criteria Patients with clinically abnormal platelet count, serum chemistry, or screening laboratory results as reviewed by the Principal Investigator Patients who have had any cosmetic procedures meant to address skin aging of face and hands 3 months prior to enrollment Patients who have had resurfacing laser on face or hands within one year prior to enrollment (...) A Pilot Study on the Use of Platelet Rich Plasma (PRP) for Facial and Hand Skin Rejuvenation A Pilot Study on the Use of Platelet Rich Plasma (PRP) for Facial and Hand Skin Rejuvenation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2018 Clinical Trials

104. Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color

Chemical peels or other facial acne procedures (laser therapy, light therapy) within 3 months of baseline Treatment with botulinum toxin of any serotype in the face within 6 months of baseline Estrogens/Birth control pills must have been started ≥ 90 days prior to baseline and use must be continued during the study without alteration or discontinuation. Pregnant or breast feeding. Subjects with evidence of alcohol or substance abuse. Use of any investigational drug within 4 weeks prior to randomization (...) Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2018 Clinical Trials

105. Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers

will be sought in the medical record on a monthly basis. The effect of iontophoresis of treprostinil on skin perfusion assessed with laser speckle contrast imaging at the site of the ulcer and around the wound [ Time Frame: day 9 ] Cutaneous perfusion will be assessed as cutaneous vascular conductance, and compared between groups Comparison of skin oxygenation around the lesion and on healed skin (when possible) [ Time Frame: Day 0 and Day 9 and week 12 ] Comparison using transcutaneous pressure of oxygen 8 (...) Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2018 Clinical Trials

106. Aesthetic considerations in female skin of color: what you need to know. (Abstract)

Aesthetic considerations in female skin of color: what you need to know. The world is flat when it comes to aesthetic treatments, meaning women and men from all walks of life, regardless of culture and ethnicity or even socioeconomic status, are seeking ways to improve their appearance, prevent aging, and rejuvenate their skin. Year after year, statistics show a steady increase in people of color undergoing aesthetic treatments, with neurotoxins, fillers, laser resurfacing, and body contouring (...) being the most sought-after procedures. When treating this cohort of patients, however, dermatologists need to be sensitized to how a patient's ethnicity affects facial structure, the tissue reaction to treatments, and patient's specific expectations for recommended therapies. A balance between tolerability and efficacy needs to be struck to minimize risk for adverse effects such as postinflammatory hyperpigmentation, which can negatively impact a patient's experience and quality of life.©2018

2018 Seminars in Cutaneous Medicine and Surgery

107. Sculptra Aesthetic for the Treatment of Upper Knee Skin Laxity

and spermicide), abstinence and/or vasectomies of partner with a documented second acceptable method of birth control, should the subject become sexually active. Must be willing to comply with study treatments and complete the entire course of the study. Exclusion Criteria: h. A subject with history of any other skin tightening procedures in the treatment area within the last 12 months. (Microfocused ultrasound, radiofrequency). i. A subject with history of bio-stimulatory products or filler injections (...) of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study. o. A subject planning any other cosmetic procedure to the study treatment area during the study period, other than the treatment that will be performed by the investigator. p. Presence of incompletely healed wound in treatment area. q. Non-Ablative laser to the treatment area in the last 3 months. r. A female subject who is pregnant, nursing an infant or planning a pregnancy during

2018 Clinical Trials

108. Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging

drugs History of photosensitivity reactions Any current or past medical condition, including seizures and stroke History of pigmentation disorder such as but not limited to vitiligo and leukoderma Immunocompromised state Pregnant or lactating (pregnancy kit will be used to check) Patients who have undergone laser, radiofrequency, peeling, and other procedural therapies for anti-aging in the month prior to the study. Patients with current inflammatory or infectious skin disease on the face (...) Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2018 Clinical Trials

109. Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes

for recalcitrant wounds. Angiogenesis and dermal fibroblast proliferation are also regulated by B2ARs. The B2AR antagonists have been found to promote angiogenesis in chick chorioallantoic membrane assays and in vivo murine wound models. Dermal fibroblast migration is also increased (by 27%) when exposed to B2AR antagonists, and epidermal differentiation is improved with B2AR antagonists and β1- and β2-receptor antagonists. Full-thickness skin grafts (FTSG) are one of the most commonly performed procedures (...) Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2018 Clinical Trials

110. Influence of Mango Intake of Skin Health in Postmenopausal Women

or more cups per day Vegetable consumption of 3 or more cups per day for females Fruit juice consumption of more than 1 cup per day Self-reported malabsorption Currently taking regular prescription drugs i.e. statins, thyroid, anti-inflammatory drugs Had any medical or cosmetic procedures such as laser resurfacing or plastic surgery to the face within the last 6 months, including botulinum toxin, dermal fillers, collagen or other similar cosmetic procedure Autoimmune photosensitive condition or known (...) Influence of Mango Intake of Skin Health in Postmenopausal Women Influence of Mango Intake of Skin Health in Postmenopausal Women - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Influence of Mango Intake

2018 Clinical Trials

111. Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity

. Skin piercing in the treatment area. Tattoos in the treatment area. Prior procedure in the treated area with laser or other device within 12 months of the initial treatment or during the course of treatment. History of keloid formation or poor wound healing in a previously-injured skin area. 21. History of epidermal or dermal disorders (particularly if involving collagen or microvascularity). 21. Use of an intrauterine device during the course of treatment. Contacts and Locations Go to Information (...) Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2018 Clinical Trials

112. A Single-Center Open-Label Study of 1064 nm Nd:YAG for Nonablative Skin Rejuvenation

Last Update Posted : February 5, 2018 See Sponsor: Cutera Inc. Information provided by (Responsible Party): Cutera Inc. Study Details Study Description Go to Brief Summary: The purpose of this investigation is to evaluate the safety and efficacy of the Cutera excel V Laser Genesis procedure utilizing the 1064nm Nd:YAG laser for skin rejuvenation. Condition or disease Intervention/treatment Phase Skin Pigment Photoaging Device: excel V Laser Not Applicable Detailed Description: This is a single (...) purposes. Agree to not undergo any other procedure(s) for skin rejuvenation during the study, including but not limited to chemical peel, laser and light based device treatment, and home-use device treatment. Agree to not undergo any injection of botulinum toxin, collagen, hyaluronic acid filler or other dermal filler during the study. Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course

2018 Clinical Trials

113. Prevention of skin cancer

5.1.3. Performance of skin cancer screening 119 5.1.4. Screening of at-risk persons 123 5.1.5. Examination intervals 124 5.1.6. What negative consequences can be associated with which screening? 125 5.2. Screening test / presumptive diagnostic procedures 128 5.2.1. Introduction 128 5.2.2. Screening test 129 5.2.3. Previous history and self-examination 132 5.2.4. Presumptive diagnostic procedures 133 5.3. Confirmatory diagnostic procedures 142 5.3.1. Confirmatory diagnostic methods 142 5.3.2. Conduct (...) of confirmatory diagnostic procedures 143 5.3.3. The histopathological diagnostic procedure 144 5.3.4. Quality assurance 147 5.4. Doctor-patient communication 148 5.4.1. Structure of the doctor-patient conversation prior to screening 148 5.4.2. Structure of the doctor-patient conversation after screening 151 5.4.3. Structure of the doctor-patient conversation for reporting findings 153 5.5. Implementation and quality assurance of skin cancer screening 154 5.5.1. Training, advanced education and continuing

2014 German Guideline Program in Oncology

114. Skin Resurfacing: Laser Surgery

in treating severely photodamaged skin, photoinduced facial rhytides, dyschromias, and atrophic scars have been favorable. In addition, LSR has been used for benign epidermal and dermal lesions and certain premalignant and . Finally, LSR can be performed as an isolated procedure or as an adjunct to procedures such as transconjunctival blepharoplasty (TCB), facelift, and endoscopic browlift. Although this technology is relatively new, its benefits are clear. The laser allows for precise control of ablation (...) Skin Resurfacing: Laser Surgery Skin Resurfacing - Laser Surgery: Background, Indications, Contraindications Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvODM4NTAxLW92ZXJ2aWV3 processing > Skin Resurfacing

2014 eMedicine Surgery

115. Skin Resurfacing, Laser: Carbon Dioxide

. Although aware of heat-induced collagen shrinkage during laser resurfacing procedure, whether this immediate shrinkage observed clinically persists or results in long-term collagen tightening is not known. Previous Next: Presentation See the list below: Obagi skin classification: This classification is probably the most comprehensive skin classification system. It analyzes skin using the following criteria: Skin color - Original (light white, dark black, dark Asian) or deviated (brunette, white, light (...) black, medium black, light Asian, medium Asian, complex skin); carbon dioxide laser resurfacing not recommended for any skin color other than light white, white, or brunette Skin thickness - Thick, thin, medium (excessively thick or thin skin is a relative contraindication to this procedure) Skin firmness - Firm versus lax Skin fragility - Tough versus fragile Skin oiliness - Oily, normal, dry Degree of photoaging: Assess by judging degree of wrinkling, precancerous growths such as actinic keratosis

2014 eMedicine Surgery

116. Skin Resurfacing, Laser: Erbium YAG

Skin Resurfacing, Laser: Erbium YAG Erbium YAG Laser Skin Resurfacing: Background, Problem, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTI5NjkwOC1vdmVydmlldw== processing > Erbium YAG Laser Skin (...) Resurfacing Updated: Aug 30, 2017 Author: Meir Cohen, MD, MPS; Chief Editor: Gregory Gary Caputy, MD, PhD, FICS Share Email Print Feedback Close Sections Sections Erbium YAG Laser Skin Resurfacing Overview Background The abundance of facial skin care regimens and their enthusiastic promotion in the popular media is the modern expression of an ancient desire to attain beauty and recapture a youthful appearance. Facial rejuvenation has been practiced for thousands of years, as can be seen in documents from

2014 eMedicine Surgery

117. The Combination Therapy of Fractional Laser and PRP Compared With Nanofat Grafting and PRP Synergy in Treating Striae Gravidarum.

, microdermabrasion, platelet-rich plasma injection(PRP), etc. To some extent, these treatments can improve striae gravidarum. In this clinical trial, the investigators are going to treat striae gravidarum by using two different kinds of combination therapies. One is fractional laser and PRP injection synergy, and the other one is treated by nanofat grafting with PRP injection. Condition or disease Intervention/treatment Phase Treatments of Striae Gravidarum Device: Fractional CO2 Laser Procedure: Nanofat (...) grafting Procedure: Platelet-rich plasma (PRP) Injection Phase 3 Detailed Description: The investigators will pick out two areas of most severe striae gravidarum on a participant's abdomen. One of the areas will be treated by fractional laser once every three months for 2 times combined with PRP injection once a month for 6 times. Another area will be treated by nanofat grafting once every three months for 2 times and PRP therapy once a month for 6 times. The participants were asked to come back 1、3、6

2017 Clinical Trials

118. Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

. Condition or disease Intervention/treatment Phase Breast Carcinoma Cancer Survivor Cervical Carcinoma Dyspareunia Vaginal Dryness Procedure: Laser Therapy Other: Questionnaire Administration Not Applicable Detailed Description: PRIMARY OBJECTIVES: I. To demonstrate the feasibility of fractionated CO2 laser treatments in patients with breast cancer with vaginal atrophy by determining treatment completion rates and tolerability of treatment. II. To demonstrate the efficacy of fractionated CO2 laser (...) Therapy for Survivors of Breast Malignancies Actual Study Start Date : November 15, 2017 Estimated Primary Completion Date : January 29, 2021 Estimated Study Completion Date : January 29, 2021 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Treatment (fractional CO2 laser therapy) Patients undergo fractional CO2 laser therapy every 4-6 weeks for 3 treatments. Procedure: Laser Therapy

2017 Clinical Trials

119. Early Carbon Dioxide Laser Therapy for Alleviation of Incisional Scar Burden

at preventing scar formation after surgery.CO2 laser therapy is currently being used by dermatologists and plastic surgeons to help with scarring after acne and to rejuvenate the face; its benefits are now being explored by medical professionals in dermatology and cosmetic surgery to prevent scarring after surgery. Condition or disease Intervention/treatment Phase Skin Scarring Other: CO2 Laser Administration Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (...) breast reduction. Thus, for this study, only female patients will be considered (see below). Any patient enrolled in this study who shows evidence of delayed wound healing, dehiscence, or post operative infection at the first post operative visit will be excluded Patients with darker skin (Fitzpatrick IV and above), which is a well-known contraindication to laser therapy Pregnant patients Patients who have had prior breast surgery Patients who have had prior chest/breast irradiation Patients

2017 Clinical Trials

120. Picosecond Laser Treatment for Tattoos and Benign Cutaneous Pigmented Lesions (Secondary publication) Full Text available with Trip Pro

lesions with less induction of post-inflammatory hyperpigmentation in the PIH-susceptible Asian skin, and dermal melanocytosis also respond very well to ps-laser treatment. Illustrative clinical examples from the author's experience are given.Current ps-lasers could be a revolutionary advance for laser tattoo removal but may be less effective for some specific aesthetic indications such as melasma and other cosmetic procedures. Manufacturers must make an effort to reduce the current comparatively long (...) Picosecond Laser Treatment for Tattoos and Benign Cutaneous Pigmented Lesions (Secondary publication) The selective removal of tattoos and benign cutaneous pigmented lesions with laser energy evolved rapidly with the development of the nanosecond-domain Q-switched laser (ns-laser). Recently, however, a series of picosecond-domain lasers (ps-lasers) with pulsewidths less than 1 ns has become commercially available, enabling more efficient and faster removal of pigmented lesions in the field

2017 Laser therapy

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>